PAPER Dayan E
SEARCH RESULTS
335775 RESULTS
PAPER Chen HH, Yeo HT, Huang YH, Tsai LK, Lai HJ, Tsao YP, Chen SL
AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice.
Skelet Muscle. 2024 Jul 24;14(1):17. PubMed.PAPER Kim S, Chun H, Kim Y, Kim Y, Park U, Chu J, Bhalla M, Choi SH, Yousefian-Jazi A, Kim S, Hyeon SJ, Kim S, Kim Y, Ju YH, Lee SE, Lee H, Lee K, Oh SJ, Hwang EM, Lee J, Lee CJ, Ryu H
Astrocytic autophagy plasticity modulates Aβ clearance and cognitive function in Alzheimer's disease.
Mol Neurodegener. 2024 Jul 23;19(1):55. PubMed.PAPER Hou Y, Liu F, Lin N, Gao S
Systematic review and meta-analysis of repetitive transcranial magnetic stimulation (rTMS) for activities of daily living in Alzheimer's disease.
Neurol Sci. 2024 Jul 23; PubMed.PAPER Kim TA, Cruz G, Syty MD, Wang F, Wang X, Duan A, Halterman M, Xiong Q, Palop JJ, Ge S
Neural circuit mechanisms underlying aberrantly prolonged functional hyperemia in young Alzheimer's disease mice.
Mol Psychiatry. 2024 Jul 24; PubMed.PAPER Magana-Ramirez CM, Irizarry-Martinez G, Gillen DL, Grill JD
Reasons for undergoing amyloid imaging among diverse enrollees in the A4 study.
Alzheimers Dement. 2024 Jul 23; PubMed.PAPER Shim JW, Hyacinth HI, Gonzalez-Perez O
Editorial: Current therapeutic approaches in Alzheimer's disease: the use of a second drug with anti-amyloid-beta and beyond.
Front Neurosci. 2024;18:1449365. Epub 2024 Jul 8 PubMed.PAPER Liu F, Li H, Hong X, Liu Y, Yu Z
Research progress of neuron-specific enolase in cognitive disorder: a mini review.
Front Hum Neurosci. 2024;18:1392519. Epub 2024 Jul 8 PubMed.PAPER Kingwell K
Antibody sniffs out tau.
Nat Rev Drug Discov. 2024 Jul 23; PubMed.PAPER Wang F, Chen Z, Zhou Q, Xie L, Zheng N, Chen Z, Lin J, Li B, Li L
Implications of Liquid-Liquid Phase Separation and Ferroptosis in Alzheimer's Disease.
Neuropharmacology. 2024 Jul 21;:110083. PubMed.PAPER Chen H, Gao X, Li X, Yu C, Liu W, Qiu J, Liu W, Geng H, Zheng F, Gong H, Xu Z, Jia J, Zhao Q
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's Disease.
J Med Chem. 2024 Jul 23; PubMed.PAPER Pina-Escudero SD, La Joie R, Spina S, Hwang JH, Miller ZA, Huang EJ, Grant H, Mundada NS, Boxer AL, Gorno-Tempini ML, Rosen HJ, Kramer JH, Miller BL, Seeley WW, Rabinovici GD, Grinberg LT
Comorbid neuropathology and atypical presentation of Alzheimer's disease.
Alzheimers Dement (Amst). 2024;16(3):e12602. Epub 2024 Jul 22 PubMed.PAPER Anandan S, Rajendran SS, Kumar JP, Shajee DS
Very Early Onset Familial Alzheimer's Disease Due to Mutation in PSEN1 I143T- First Case Report from South Asia.
Neurol India. 2024 May 1;72(3):652-654. Epub 2024 Jun 30 PubMed.PAPER Yang Y, Nie X, Wang Y, Sun J, Gao X, Zhang J
Evolving insights into erythrocytes in synucleinopathies.
Trends Neurosci. 2024 Jul 22; PubMed.PAPER Frigerio I, Broeders TA, Lin CP, Bouwman MM, Koubiyr I, Barkhof F, Berendse HW, Van De Berg WD, Douw L, Jonkman LE
Pathologic Substrates of Structural Brain Network Resilience and Topology in Parkinson Disease Decedents.
Neurology. 2024 Aug 27;103(4):e209678. Epub 2024 Jul 23 PubMed.Current Filters
No filters selected